These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17387457)

  • 1. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
    Pattij T; Janssen MC; Schepers I; González-Cuevas G; de Vries TJ; Schoffelmeer AN
    Psychopharmacology (Berl); 2007 Jul; 193(1):85-96. PubMed ID: 17387457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.
    Wiskerke J; Stoop N; Schetters D; Schoffelmeer AN; Pattij T
    PLoS One; 2011; 6(10):e25856. PubMed ID: 22016780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
    Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of morphine on distinct forms of impulsive behavior in rats.
    Pattij T; Schetters D; Janssen MC; Wiskerke J; Schoffelmeer AN
    Psychopharmacology (Berl); 2009 Aug; 205(3):489-502. PubMed ID: 19436995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory gating in rat hippocampus and medial prefrontal cortex: effect of the cannabinoid agonist WIN55,212-2.
    Dissanayake DW; Zachariou M; Marsden CA; Mason R
    Neuropharmacology; 2008 Dec; 55(8):1397-404. PubMed ID: 18809420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.
    Chen SF; Hsu WC; Lu XY; Chuang CY; Liao RM
    Psychopharmacology (Berl); 2022 May; 239(5):1459-1473. PubMed ID: 34741633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder.
    Leffa DT; Ferreira SG; Machado NJ; Souza CM; Rosa FD; de Carvalho C; Kincheski GC; Takahashi RN; Porciúncula LO; Souza DO; Cunha RA; Pandolfo P
    Eur J Neurosci; 2019 Jun; 49(12):1673-1683. PubMed ID: 30667546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
    Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
    Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
    Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.
    McAllister SD; Rizvi G; Anavi-Goffer S; Hurst DP; Barnett-Norris J; Lynch DL; Reggio PH; Abood ME
    J Med Chem; 2003 Nov; 46(24):5139-52. PubMed ID: 14613317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
    Fattore L; Spano M; Melis V; Fadda P; Fratta W
    Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
    Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
    J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control.
    Son MH; Kim HD; Chae YN; Kim MK; Shin CY; Ahn GJ; Choi SH; Yang EK; Park KJ; Chae HW; Moon HS; Kim SH; Shin YG; Yoon SH
    Int J Obes (Lond); 2010 Mar; 34(3):547-56. PubMed ID: 20029379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
    Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R
    J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
    de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
    Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.